 PREPARATIVE REGIMEN: Patients receive fludarabine phosphate intravenously IV over 30 minutes on days -5 to -3 and intermediate-dose melphalan IV over 15-20 minutes on day -2. Patients also undergo low-dose TBI on day 0. 